fastandbulbous
Bluelight Crew
The following is an extract from NIDA monograph 149 - Hallucinogens; an update
These seem to indicate that low doses of DMT have characteristics that are also common to opiate drugs; but would seem to go against the use of hallucinogens by opiate users, some actually equating the effects of psychedelic agents to a withdrawl syndrome.
The thing I was wondering was, is this something specific to DMT (and 5-methoxy DMT possibly due to their endogenous role as a neurotransmitter/neuroendocrine agent) or is it something common to all psychedelic agents acting via 5HT mechanisms, and if not, is this linked to DMT's ( and 5-methoxy DMT) agonist action at the 5HT1a receptor
The negative melatonin data are inconsistent with DMT’s biological effects being mediated by nonspecific stress rather than by selective serotonin receptor subtype activation. The rise in beta-endorphin seen in this study is more than twice that seen after a 28.5 mile mountain race in which daytime melatonin levels doubled (Strassman et al. 1989).
0.05 mg/kg: One-third of the subjects mistook this dose for placebo. Those who were able to distinguish the dose from saline remarked on its uniformly relaxing, comfortable, and warm physical effects. One former heroin user likened it to the “soft cotton batting” of heroin. There were no perceptual (auditory or visual) effects at this dose.
These seem to indicate that low doses of DMT have characteristics that are also common to opiate drugs; but would seem to go against the use of hallucinogens by opiate users, some actually equating the effects of psychedelic agents to a withdrawl syndrome.
The thing I was wondering was, is this something specific to DMT (and 5-methoxy DMT possibly due to their endogenous role as a neurotransmitter/neuroendocrine agent) or is it something common to all psychedelic agents acting via 5HT mechanisms, and if not, is this linked to DMT's ( and 5-methoxy DMT) agonist action at the 5HT1a receptor